1. Home
  2. THM vs RLMD Comparison

THM vs RLMD Comparison

Compare THM & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Tower Hill Mines Ltd. (Canada)

THM

International Tower Hill Mines Ltd. (Canada)

HOLD

Current Price

$1.24

Market Cap

402.9M

Sector

N/A

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

SELL

Current Price

$3.03

Market Cap

348.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
THM
RLMD
Founded
1978
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
402.9M
348.8M
IPO Year
2002
2012

Fundamental Metrics

Financial Performance
Metric
THM
RLMD
Price
$1.24
$3.03
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $10.75
AVG Volume (30 Days)
1.6M
★ 1.7M
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.28
EPS
★ N/A
N/A
Revenue
N/A
★ $13,070.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 154.83
52 Week Low
$1.07
$2.98
52 Week High
$3.65
$8.00

Technical Indicators

Market Signals
Indicator
THM
RLMD
Relative Strength Index (RSI) 30.30 36.77
Support Level $1.07 N/A
Resistance Level $2.88 $3.55
Average True Range (ATR) 0.19 0.43
MACD -0.03 -0.04
Stochastic Oscillator 15.66 1.45

Price Performance

Historical Comparison
THM
RLMD

About THM International Tower Hill Mines Ltd. (Canada)

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project, namely the Livengood Gold Project. It is located in the northwest of Fairbanks, Alaska, in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: